ATMP regulation in EU and FDA

EU ATMPs Quality Regulation

Featured Fireside Chat: Brexit's Effect on Cell and Gene Therapy Regulation

Regulatory considerations for CGT products with the MHRA (UK) and EU National Competent Authorities

A-Gene: Regulatory Considerations

The Future of ATMPs in Europe

The European cell & gene therapy landscape

Introduction to Advanced Therapy Medicinal Products (ATMPs) in the EU

Opportunities for Regulatory Convergence in Cell and Gene Therapy

Plenary Session: A New Era for ATMPs – Commercializing in the EU

Navigating regulatory challenges for cell and gene therapy products in 2024 and beyond

Session 2 Cell and Gene Therapy - ENG/한글자막

Safety, testing and regulations of Cell and Gene Therapies (Alcyomics)

Commercial and Regulatory Success in Accelerated Gene Therapy Development

Regulatory considerations for Cell and Gene Therapies - Jim DeKloe

Supporting the future of ATMPs in the EU

Panel Discussion on Gene Therapy Policy in Europe

Cell and Gene Therapy Clinical Trials: How to Successfully Operationalize a Trial

Panel: Trends and Challenges in Gene Therapy in Europe

A-Cell: Regulatory Considerations